Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

astrazeneca ab - anifrolumab - Лупус еритематозус, системен - Имуносупресори - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.

Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

serb sa - amifampridine phosphate - lambert-eaton myasthenic syndrome; paraneoplastic syndromes, nervous system; nervous system neoplasms; paraneoplastic syndromes; nervous system diseases; autoimmune diseases of the nervous system; neurodegenerative diseases; neuromuscular diseases; neuromuscular junction diseases; immune system diseases; autoimmune diseases; autoimmune diseases of the nervous system; cancer; neoplasms - Други лекарства в нервната система - Симптоматично лечение на миастенен синдром на lambert-eaton (lems) при възрастни.

Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - spesolimab - псориазис - Имуносупресори - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.

Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

csl behring gmbh - etranacogene dezaparvovec - Хемофилия Б - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.